Opportunities and challenges with animal models for acute radiation syndrome drug discovery
JournalExpert Opinion on Drug Discovery
PublisherTaylor and Francis Ltd
MetadataShow full item record
SponsorsThe authors gratefully acknowledge intramural research support from the Armed Forces Radiobiology Research Institute (RBB29173).
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85054195521&doi=10.1080%2f17460441.2018.1526172&partnerID=40&md5=199279b8f93c9c041fdeb6cc81745985; http://hdl.handle.net/10713/8840
- Animal models for acute radiation syndrome drug discovery.
- Authors: Singh VK, Newman VL, Berg AN, MacVittie TJ
- Issue date: 2015 May
- Nonhuman primates as models for the discovery and development of radiation countermeasures.
- Authors: Singh VK, Olabisi AO
- Issue date: 2017 Jul
- Radioprotective Efficacy of Gamma-Tocotrienol in Nonhuman Primates.
- Authors: Singh VK, Kulkarni S, Fatanmi OO, Wise SY, Newman VL, Romaine PL, Hendrickson H, Gulani J, Ghosh SP, Kumar KS, Hauer-Jensen M
- Issue date: 2016 Mar
- Are animal models a necessity for acute radiation syndrome drug discovery?
- Authors: Schaue D, McBride WH
- Issue date: 2019 Jun
- Use of biomarkers for assessing radiation injury and efficacy of countermeasures.
- Authors: Singh VK, Newman VL, Romaine PL, Hauer-Jensen M, Pollard HB
- Issue date: 2016